Improvement on a symptom scale does not establish treatment of an entire neurological syndrome.
What the supplied paper reports
A Ugandan pilot evaluated catatonic features in children with nodding syndrome. Sixteen of thirty-three met the study’s catatonia criteria. Some responded substantially to lorazepam, including several who responded only after a second administration.
Study limits
The sample was small and selected, without a controlled long-term treatment comparison. Overlap between syndrome features and rating items complicates interpretation.
Forensic implications
Specify the symptoms that changed and the timing of each assessment. A response can support evaluating catatonia while not proving its cause or predicting long-term neurological recovery. The study does not establish a universal benzodiazepine regimen for nodding syndrome or all childhood regression.
Source and related reading
Source: PMC4693437, supplied full-text paper. Findings are paraphrased; forensic implications are an interpretation.
Related: A Lorazepam Response in a Cannabis-Associated Catatonia Case Did Not Prove Cannabis Causation.
Leave a Reply